What's in Medicines for Malaria Venture's pipeline?

Medicines for Malaria Venture has 28 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 23 in Phase 1.

Which companies overlap with Medicines for Malaria Venture's portfolio?

Top competitors by shared drug class: Professor Anders Björkman, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Centers for Disease Control and Prevention, London School of Hygiene and Tropical Medicine, University of Oxford.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/medicines-for-malaria-venture.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Medicines for Malaria Venture — Portfolio Competitive Intelligence Brief

Medicines for Malaria Venture pipeline: 2 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 2 Phase 2 23 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Pyronaridine artesunate	Pyronaridine artesunate	marketed	Antimalarial combination	Plasmodium falciparum DNA; heme detoxification pathway	Infectious Disease
PQP	PQP	marketed	Quinolone antimalarial	Plasmodium DNA gyrase and topoisomerase II	Infectious Disease
Mefloquine plus artesunate	Mefloquine plus artesunate	phase 3	Antimalarial combination therapy		Infectious Disease

Therapeutic area mix

Infectious Disease · 3
Other · 2
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Professor Anders Björkman · 2 shared drug classes
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado · 2 shared drug classes
Centers for Disease Control and Prevention · 2 shared drug classes
London School of Hygiene and Tropical Medicine · 2 shared drug classes
University of Oxford · 2 shared drug classes
Epicentre · 1 shared drug class
Charite University, Berlin, Germany · 1 shared drug class
Bernhard Nocht Institute for Tropical Medicine · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Medicines for Malaria Venture:

Cite this brief

Drug Landscape (2026). Medicines for Malaria Venture — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/medicines-for-malaria-venture. Accessed 2026-05-16.